Z-0789-2014 Class I Terminated
FDA device recall Z-0789-2014 was initiated by Codman & Shurtleff, Inc. on Oct 11, 2013 and is designated Class I. Reason for recall: Incorrect instructions for use (IFU). The recall status is terminated (terminated Jul 28, 2015). Affected quantity: 7,983.
Recall details
- Product Type
- Devices
- Report Date
- Jan 29, 2014
- Initiation Date
- Oct 11, 2013
- Termination Date
- Jul 28, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,983
Product description
TRUFILL¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System: One 1 g tube of n-BCA, one 10 mL vial of Ethiodized Oil and one 1 g vial of Tantalum Powder Product Code: 631-500 The TRUFILL n-BCA Liquid Embolic System is indicated for the embolization of cerebral arteriovenous malformations (AVMs) when pre-surgical devascularization is desired. The system is used under fluoroscopic guidance to obstruct or reduce blood flow to cerebral arteriovenous malformations (AVMs) via superselective catheter delivery.
Reason for recall
Incorrect instructions for use (IFU).
Distribution pattern
Worldwide Distribution: US (nationwide) including Puerto Rico; and internationally to: Costa Rica and Russia.
Code information
All lot codes
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0789-2014
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Codman & Shurtleff, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.